Published On: Thu, Mar 29th, 2018

Japanese firm Takeda Pharmaceutical eyes up Shire as it considers an approach

SHARES in FTSE 100 drugmaker Shire soared 430p to 3500p after it emerged as a £35billion takeover target for Japan’s biggest pharma company. Takeda Pharmaceutical is considering an approach to Shire as it looks to strengthen its core therapeutic areas of oncology and neuroscience.
Daily Express :: City and Business Feed